Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
Multiple Allele Traits01:49

Multiple Allele Traits

34.2K
The Concept of Multiple Allelism
34.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

333
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
333
What is Genetic Engineering?00:49

What is Genetic Engineering?

74.2K
Overview
74.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hematopoietic Stem Cell Transplant and Brain Volume Changes in Adults With Sickle Cell Disease.

Neurology·2026
Same author

Ten years of clinical genetic therapies for sickle cell disease: Current and future directions.

Seminars in hematology·2026
Same author

Clonal dynamics, tolerance, and adverse events after CD45-ADC-conditioned autologous HSPC transplantation in macaques.

Blood advances·2026
Same author

Fetal Hemoglobin Research and Clinical Relevance in Sickle Cell Disease.

Physiology (Bethesda, Md.)·2025
Same author

Clinical data comparison for FDA-approved gene therapies in sickle cell disease.

Experimental biology and medicine (Maywood, N.J.)·2025
Same author

Comparative analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine model.

Blood advances·2025

Related Experiment Video

Updated: Jul 9, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.7K

Gene therapy for sickle cell disease.

Alexis Leonard1, John F Tisdale2

  • 1St. Jude Children's Research Hospital, Memphis, TN.

Hematology. American Society of Hematology. Education Program
|December 9, 2023
PubMed
Summary

Gene therapy offers a potential cure for sickle cell disease (SCD) by using autologous hematopoietic stem cell transplantation (HSCT). Current gene addition and editing strategies show promising results for SCD treatment.

More Related Videos

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

9.9K
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

3.6K

Related Experiment Videos

Last Updated: Jul 9, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.7K
Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

9.9K
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

3.6K

Area of Science:

  • Hematology
  • Gene Therapy
  • Genetic Medicine

Background:

  • Sickle cell disease (SCD) is a debilitating inherited blood disorder.
  • Allogeneic hematopoietic stem cell transplantation (HSCT) offers a potential cure but faces limitations like donor availability and graft-versus-host disease.
  • Autologous HSCT combined with gene therapy presents an alternative approach to overcome these challenges.

Purpose of the Study:

  • To review the progress and potential of gene therapy for curing sickle cell disease.
  • To highlight the advantages of autologous HSCT with gene modification over allogeneic HSCT.
  • To discuss ongoing research and future directions in developing safe and effective gene therapies for SCD.

Main Methods:

  • Review of recent advancements in gene therapy strategies for SCD.
  • Analysis of clinical trial data for gene addition and gene editing approaches.
  • Evaluation of the efficacy, durability, and safety of current gene therapy protocols.

Main Results:

  • Gene therapy, particularly autologous HSCT with genetic modification, shows promising results for SCD cure.
  • Clinical trials are investigating various gene addition and gene editing techniques.
  • Early patient data suggest a potentially curative strategy, though long-term follow-up is ongoing.

Conclusions:

  • Autologous HSCT with gene therapy is a promising strategy to overcome limitations associated with allogeneic HSCT for SCD.
  • Continued research focuses on enhancing the efficacy, durability, and safety of gene therapies for SCD.
  • Gene therapy holds significant potential for a curative treatment for sickle cell disease.